| Pharmaceutical active ingredients: |
| Terazosin Hydrochloride |
| Available forms, composition and doses of Sinalfa: |
| Tablets; Oral; Terazosin Hydrochloride 2 mgTablets; Oral; Terazosin Hydrochloride 5 mg |
| Sinalfa medical category: |
| Human:Alpha-adrenergic blocking agentsAntihypertensivesDrugs for bladder and prostate disorders |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G04CA03 - Terazosin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Abbott |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Sin-A-Gen | Nonoxinol; Polysaccharide Polysulfuric Acid Ester | Altana Pharma |
| Sinahill | Acetaminophen; Cetirizine Dihydrochloride; Phenylephrine Hydrochloride | Daffohils Pharma |
| Sinalar | Fluocinolone Acetonide | Unidentified Pharmaceutical Company |
| Sinaler | Loratadine | Pablo Cassara Laboratorios |
| Sinaler B | Betamethasone; Loratadine | Pablo Cassara Laboratorios |
| Sinalgia | Fepradinol Hydrochloride | Hormona Laboratorios; Silesia Laboratorios |
| Sinalgico | Ketorolac | Microsules y Bernabo |
| Sin-Algin | Acetaminophen; Chlormezanone | Instituto Sanitas |
| Sinall Formula | Berberis Vulgaris Fructus; Phosphorus; Sambucus Nigra; Teucrium Scorodonia | Weleda |
| Sinamida Cicatrizante | Vitamin D2 (Ergocalciferol); Zinc Oxide | E. J. Gezzi Laboratorios |